Mechanically, we revealed the potential role of ZNF419 in pan-cancer from the perspective of ferroptosis, in which Fanconi anemia complementation group D2 (FANCD2) may serve as a bridge gene along with ZNF419 and ferroptosis. Here, FANCD2 is linked to cancer.